Skip to main content

Coloplast Launches New Catheter in the U.S.

Written by Customer Service on . Posted in Public Companies.

Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022.  

The new SpeediCath Flex Set with a “no touch dry sleeve” and an omni-directional tip is available as a catheter and bag solution, also called a Closed System. All SpeediCath® catheters feature Triple Action Coating Technology which is designed to reduce the risk of urethral damage and Urinary Tract Infections (UTIs)*1 and are an option for those with spinal cord injuries (SCI).

“With SpeediCath Flex Set, we are introducing an important solution for people living with SCI and many other health conditions. We are confident that its new innovative design will make a big difference to our users, improving their catheterization routine in many ways,” says Senior Vice President Manu Varma, Chronic Care in North America.

A recent estimate2 shows that the annual incidence of SCI is about 18,000 cases each year in the U.S. and the majority of the SCI patients will suffer from Neurogenic Bladder Dysfunction (NBD). Patients with NBD have significant challenges to their well-being, ranging from incontinence, renal impairment, and urinary tract infections to bladder stones and a generally poor quality of life.3

The SpeediCath Flex Set is a gentle, all-in-one solution. It has features that help patients confidently catheterize at home or away, supporting them in managing their condition and maintaining a healthy lifestyle. Find more information about SpeediCath Flex Set here.

About Coloplast’s Continence Care Products 
Coloplast aims to deliver effective solutions for bladder and bowel control. By continuously gathering feedback from clinicians and patients, the company innovates to solve urinary problems such as incontinence and retention. Coloplast also offers additional support through its Coloplast® Care program, which provides product and lifestyle advice, inspiration, and education resources for people living with bladder issues.

About Coloplast 
Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit Coloplast.us for more information. 
 

This information is intended to be an educational resource and presented for general information purposes only. It is not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician with respect to any patient needs or circumstances. Prior to use, please refer to the product ‘Instructions for Use’ for the intended use and relevant safety information.

* Compared to uncoated catheters

  1. Rognoni C, Tarricone R. Intermittent catheterization with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analyses. BMC Urol. 2017 Jan 10;17(1):4. doi: 10.1186/s12894-016-0191-1.PMID: 28073354; PMCID: PMC5225586.
  2. The National Spinal Cord Injury Database, 2020 SCI Datasheet
  3. Neurogenic bladder in spinal cord injury patients – PMC (nih.gov)

Global press contact 
Peter Mønster, Senior Media Relations Manager 
+45 4911 2623 
Dkpete@coloplast.com
    
U.S. press contact 
Kate Merwin, Head of Communications 
612-286-2455 
uskame@coloplast.com 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.